Literature DB >> 8262198

The MAP kinase-activated protein kinase 2 contains a proline-rich SH3-binding domain.

K Engel1, K Plath, M Gaestel.   

Abstract

The protein sequence of MAP kinase-activated protein kinase 2 (MAPKAP kinase 2) deduced from mouse cDNA sequence reveals structural features of the enzyme, which could be of importance for its function: a proline-rich SH3-binding domain N-terminal to the catalytic region, a MAP kinase phosphorylation site and a bipartite nuclear targeting sequence located C-terminal to the catalytic region. The catalytic domain itself has the strongest homology to calcium/calmodulin-dependent protein kinase II. Northern blot analysis demonstrates a 3.5 kb MAPKAP kinase 2 transcript which is ubiquitously expressed and, hence, co-expressed with the mRNA of the recently identified substrate Hsp25 in all tissues analysed. However, the functional consequences of the nuclear targeting sequence present in MAPKAP kinase 2 suggest the existence of further substrates for the enzyme in the nucleus.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8262198     DOI: 10.1016/0014-5793(93)81628-d

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  11 in total

Review 1.  ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions.

Authors:  Philippe P Roux; John Blenis
Journal:  Microbiol Mol Biol Rev       Date:  2004-06       Impact factor: 11.056

2.  Identifying protein construct variants with increased crystallization propensity--a case study.

Authors:  Guido A Malawski; Roman C Hillig; Felipe Monteclaro; Uwe Eberspaecher; Arndt A P Schmitz; Kerstin Crusius; Martina Huber; Ursula Egner; Peter Donner; Beate Müller-Tiemann
Journal:  Protein Sci       Date:  2006-12       Impact factor: 6.725

3.  3pK, a new mitogen-activated protein kinase-activated protein kinase located in the small cell lung cancer tumor suppressor gene region.

Authors:  G Sithanandam; F Latif; F M Duh; R Bernal; U Smola; H Li; I Kuzmin; V Wixler; L Geil; S Shrestha
Journal:  Mol Cell Biol       Date:  1996-03       Impact factor: 4.272

4.  Characterization of a novel MK3 splice variant from murine ventricular myocardium.

Authors:  Nadège Moïse; Dharmendra Dingar; Aida M Mamarbachi; Louis R Villeneuve; Nada Farhat; Matthias Gaestel; Maya Khairallah; Bruce G Allen
Journal:  Cell Signal       Date:  2010-06-04       Impact factor: 4.315

Review 5.  Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases.

Authors:  Marie Cargnello; Philippe P Roux
Journal:  Microbiol Mol Biol Rev       Date:  2011-03       Impact factor: 11.056

6.  MNK1, a new MAP kinase-activated protein kinase, isolated by a novel expression screening method for identifying protein kinase substrates.

Authors:  R Fukunaga; T Hunter
Journal:  EMBO J       Date:  1997-04-15       Impact factor: 11.598

7.  Scaffolding by ERK3 regulates MK5 in development.

Authors:  Stefanie Schumacher; Kathrin Laass; Shashi Kant; Yu Shi; Axel Visel; Achim D Gruber; Alexey Kotlyarov; Matthias Gaestel
Journal:  EMBO J       Date:  2004-11-11       Impact factor: 11.598

8.  Leptomycin B-sensitive nuclear export of MAPKAP kinase 2 is regulated by phosphorylation.

Authors:  K Engel; A Kotlyarov; M Gaestel
Journal:  EMBO J       Date:  1998-06-15       Impact factor: 11.598

9.  Elimination of protein kinase MK5/PRAK activity by targeted homologous recombination.

Authors:  Yu Shi; Alexey Kotlyarov; Kathrin Laabeta; Achim D Gruber; Elke Butt; Katrin Marcus; Helmut E Meyer; Anke Friedrich; Hans-Dieter Volk; Matthias Gaestel
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

10.  Identification of novel phosphorylation sites required for activation of MAPKAP kinase-2.

Authors:  R Ben-Levy; I A Leighton; Y N Doza; P Attwood; N Morrice; C J Marshall; P Cohen
Journal:  EMBO J       Date:  1995-12-01       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.